The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 10, 2014

Filed:

Feb. 20, 2008
Applicants:

Ning Chai, Philadelphia, PA (US);

John M. Taylor, Cheltenham, PA (US);

Inventors:

Ning Chai, Philadelphia, PA (US);

John M. Taylor, Cheltenham, PA (US);

Assignee:

Fox Chase Cancer Center, Philadelphia, PA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A01N 37/18 (2006.01); A61P 1/16 (2006.01); A61P 31/12 (2006.01); A61K 38/16 (2006.01); A61K 39/00 (2006.01); C07K 5/00 (2006.01); C07K 7/00 (2006.01); C07K 16/00 (2006.01); C07K 17/00 (2006.01); C12P 21/08 (2006.01); C12N 7/00 (2006.01); C12N 7/01 (2006.01);
U.S. Cl.
CPC ...
Abstract

A polypeptide comprising a preS1 region of hepatitis B virus (HBV), or a fragment thereof, and/or the preS2 region of HBV or a fragment thereof, and methods of use to inhibit virus infection are disclosed. A lentivirus comprising hepatitis B virus (HBV) envelope proteins, or a fragment thereof, and/or the L envelope protein of HBV and/or the M envelope protein of HBV or a fragment thereof, and/or the S envelope protein of HBV or a fragment thereof, and methods of use of this lentivirus HBV pseudovirus as a gene therapy to target hepatocytes for the administration of therapeutic agents are also disclosed.


Find Patent Forward Citations

Loading…